Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis (Nefertiti)
A Randomised, Double-blind, Placebo-controlled Study to Evaluate Clinical Performance and Safety of the Gedea Pessary in Adult Women With Bacterial Vaginosis
Sponsor: Gedea Biotech AB
This NA trial investigates Bacterial Vaginosis and is currently completed. Gedea Biotech AB leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Sep 2021 — Mar 2022 [monthly]
Recruiting NA
-
Mar 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gedea Biotech AB
For direct contact, visit the study record on ClinicalTrials.gov .